References
- 1. SIEGEL R, MA J, ZOU Z, JEMAL A. Cancer statistics. CA Cancer J Clin. 2014; 64:9–29.
- 2. RAWLA P, SUNKARA T, GADUPUTI V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019;10(1):10–27.
- 3. ZABRON A, EDWARDS RJ, KHAN SA. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Dis Model Mech. 2013;6(2):281–292.
- 4. GOUMA DJ, VAN GEENEN R, VAN GULIK T, DE WIT LT, OBERTOP H. Surgical palliative treatment in bilio-pancreatic malignancy. Ann Oncol. 1999;10 Suppl 4:269–272.
- 5. AMERICAN CANCER SOCIETY. Survival rates for bile duct cancer [online]. 2019 https://www.cancer.org/cancer/bile-duct-cancer/detection-diagnosisstaging/survival-by-stage.html.
- 6. KIRSTEIN MM, VOGEL A. Epidemiology and Risk Factors of Cholangiocarcinoma [published correction appears in Visc Med. 2017 Jun;33(3):226]. Visc Med. 2016;32(6):395–400.
- 7. HUANG L, JANSEN L, BALAVARCA Y, BABAEI M, VAN DER GEEST L, LEMMENS V, et al. Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study. BMC Med. 2018;16(1):125.
- 8. MIHALACHE F, TANTAU M, DIACONU B, ACALOVSCHI M. Survival and quality of life of cholangiocarcinoma patients: a prospective study over a 4 year period. J Gastrointestin Liver Dis. 2010;19(3):285–290.
- 9. KAASSIS M, BOYER J, DUMAS R, PONCHON T, COUMAROS D, DELCENSERIE R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc. 2003;57(2): 178–182.
- 10. LA VECCHIA C, ROTA M, MALVEZZI M, NEGRI E. Potential for improvement in cancer management: reducing mortality in the European Union. Oncologist. 2015;20(5):495–498.
- 11. Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, et al. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017;15(8):1028–1061.
- 12. BENSON AB 3RD, ABRAMS TA, BEN-JOSEF E, BLOOMSTON MP, BOTHA JF, CLARY BM, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw. 2009;7(4):350–391.
- 13. CONILL C, VERGER E, SALAMERO M. Performance status assessment in cancer patients. Cancer. 1990;65(8):1864–1866.
- 14. VALERO V 3RD, COSGROVE D, HERMAN JM, PAWLIK TM. Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Rev Gastroenterol Hepatol. 2012;6(4):481–495.
- 15. HOFMARCHER T, LINDGREN P, WILKING N, JÖNSSON B. The cost of cancer in Europe 2018. European Journal of Cancer 129:41–49.
- 16. GAŃCZAK M, MIAZGOWSKI T, KOŻYBSKA M, KOTWAS A, KORZEŃ M, RUDNICKI B, et al. Changes in disease burden in Poland between 1990–2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017. PLoS One. 2020 Mar 2;15(3):e0226766
- 17. CHARI ST. Detecting early pancreatic cancer: problems and prospects. Semin Oncol. 2007;34(4):284–294.
- 18. PIANO M, BLACK G, AMELUNG D, POWER E, WHITAKER KL. Exploring public attitudes towards the new Faster Diagnosis Standard for cancer: a focus group study with the UK public. Br J Gen Pract. 2019;69(683):e413–e421.
- 19. KHAN SA, DAVIDSON BR, GOLDIN R, PEREIRA SP, ROSENBERG WMC, TAYLOR-ROBINSON SD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;51 Suppl 6(Suppl 6):VI1–VI9.
- 20. JEMAL A, MURRAY T, WARD E, SAMUELS A, TIWARI RC, GHAFOOR A, et al. Cancer statistics, 2005 [published correction appears in CA Cancer J Clin. 2005 Jul-Aug;55(4):259]. CA Cancer J Clin. 2005;55(1):10–30.
- 21. VINCENT A, HERMAN J, SCHULICK R, HRUBAN RH, GOGGINS M. Pancreatic cancer. Lancet. 2011;378(9791): 607–620.
- 22. SCHEITHAUER W, PUTORA PM, GRÜNBERGER B, EISTERER W, WÖLL E, PRAGER G, et al. Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine [published correction appears in Therap Adv Gastroenterol. 2019 Sep 23;12:1756284819877635
- 23. PEIXOTO RD, RENOUF D, LIM H. A population based analysis of prognostic factors in advanced biliary tract cancer. J Gastrointest Oncol. 2014;5(6):428–432.
- 24. HUIBREGTSE K, CARR-LOCKE DL, CREMER M, DOMSCHKE W, FOCKENS P, FOERSTER E, et al. Biliary stent occlusion-a problem solved with self-expanding metal stents? European Wallstent Study Group. Endoscopy. 1992;24(5): 391–394.
- 25. KNYRIM K, WAGNER HJ, PAUSCH J, VAKIL N. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy. 1993;25(3):207–212.
- 26. MOY BT, BIRK JW. An Update to Hepatobiliary Stents. J Clin Transl Hepatol. 2015;3(1):67–77.
- 27. SCHMIDT M, SCHMIDT SAJ, ADELBORG K, SUNDBØLL J, LAUGESEN K, EHRENSTEIN V, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563-591.
- 28. HIRIPI, E., GONDOS, A., EMRICH, K., HOLLECZEK, B., KATALINIC, A., LUTTMANN, S. Survival from common and rare cancers in Germany in the early 21st century. Annals of Oncology 2011; 23(2):472–479.
- 29. DEYO D, KHALIQ A, MITCHELL D, HUGHES DR. Electronic sharing of diagnostic information and patient outcomes. Am J Manag Care. 2018;24(1):32–37
- 30. KRUSE CS, KRISTOF C, JONES B, MITCHELL E, MARTINEZ A. Barriers to Electronic Health Record Adoption: a Systematic Literature Review. J Med Syst. 2016 Dec;40(12):252.
- 31. GAVIN DR, VALORI RM, ANDERSON JT, DONNELLY MT, WILLIAMS JG, SWARBRICK ET. The national colonoscopy audit: a nationwide assessment of the quality and safety of colonoscopy in the UK. Gut. 2013;62(2):242–9.